Join the 'Acute Lymphocytic Leukemia' group to help and get support from people like you. How it works
Acute Lymphocytic Leukemia Blog
Related terms: Acute childhood leukemia, Acute Lymphocytic Leukemia (ALL), Cancer, Acute Childhood Leukemia, Cancer, Acute Lymphocytic Leukemia, Leukemia, Acute Childhood, Leukemia, Acute Lymphocytic, ALL
| Tweet |
FDA Approves Erwinaze to Treat Acute Lymphoblastic Leukemia
Posted 18 Nov 2011 by Drugs.com
November 18, 2011 – The U.S. Food and Drug Administration today approved Erwinaze (asparaginase Erwinia chrysanthemi) to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegapargase chemotherapy drugs used to treat ALL. Acute lymphoblastic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell. White blood cells help the body fight infection and are formed in the bone marrow. Erwinaze is injected directly into the muscle three times a week and works by breaking down one of the body’s protein building blocks (the amino acid, asparagine) that is present in the blood, and is necessary for the growth of all cells. Leukemia cells cannot produce this protein building block. When a patient is treated with Erwinaze the leukemia cells die. Normal h ... Read more
Related support groups: Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Lymphocytic Leukemia (ALL)
Death Rate Higher in Minorities With Acute Leukemia
Posted 22 Sep 2011 by Drugs.com
THURSDAY, Sept. 22 – A new study finds that blacks and Hispanics are less likely to develop acute leukemia than whites. But if they do become ill, they're much more likely to die. "We don't know the reason for the disparity, but now that we know it exists we can investigate why it occurs," said study lead researcher Dr. Manali I. Patel, postdoctoral fellow in hematology/oncology at the Stanford Cancer Institute in Stanford, Calif., in a statement provided by the American Association for Cancer Research. "Like all disparities in cancer, there could be any combination of influences; however, we believe that socioeconomic factors and access to care may be playing an important role." After studying medical records of nearly 41,000 patients with acute leukemia between 1998 and 2008, the researchers found that blacks had a 17 percent higher risk of dying of acute leukemia than whites, and ... Read more
Related support groups: Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Promyelocytic Leukemia, Acute Nonlymphocytic Leukemia, Acute Myeloblastic Leukemia
Study Finds Big Strides Made in Treating Leukemia, Lymphoma in Past Decade
Posted 24 Nov 2010 by Drugs.com
WEDNESDAY, Nov. 24 – Clinicians have made remarkable advances in treating blood cancers with bone marrow and blood stem cell transplants in recent years, significantly reducing the risk of treatment-related complications and death, a new study shows. Between the early 1990s and 2007, there was a 41 percent drop in the overall risk of death in an analysis of more than 2,500 patients treated at Fred Hutchinson Cancer Center in Seattle, a leader in the field of blood cancers and other malignancies. Researchers from the Fred Hutchinson Cancer Center, who conducted the study, also noted dramatic decreases in treatment complications such as infection and organ damage. The study was published in the Nov. 24 issue of the New England Journal of Medicine "We have made enormous strides in understanding this very complex procedure and have yielded quite spectacular results," said study senior ... Read more
Related support groups: Hairy Cell Leukemia, Leukemia, Chronic Myelogenous Leukemia (CML), Lymphoma, Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Cutaneous T-cell Lymphoma, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Acute Lymphocytic Leukemia, Acute Promyelocytic Leukemia, Follicular Lymphoma, Acute Nonlymphocytic Leukemia, Infection Prophylaxis, Chronic Lymphocytic Leukemia
Kids Who Beat Cancer Still Face Heart Risks
Posted 9 Dec 2009 by Drugs.com
WEDNESDAY, Dec. 9 – Survivors of childhood cancer have a significantly increased risk for developing heart disease as young adults, a new study finds. The finding came from an analysis of data on 14,358 five-year cancer survivors who were diagnosed before age 21 and 3,899 siblings of cancer survivors. The cancers were leukemia, brain cancer, Hodgkin's lymphoma, non-Hodgkin's lymphoma, kidney cancer, neuroblastoma, soft tissue carcinoma or bone cancer. The study found that young adult survivors of these childhood cancers are much more likely than others in their age group to have cardiovascular problems, including heart failure, heart attack, heart inflammation and heart valve abnormalities, for up to 30 years after being treated for cancer. They also found that the risk was associated with lower exposure to chemotherapy and radiation treatment than previously thought. "Young adults who ... Read more
Related support groups: Hairy Cell Leukemia, Leukemia, Chronic Myelogenous Leukemia (CML), Brain Tumor, Renal Cell Carcinoma, Osteosarcoma, Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Glioblastoma Multiforme, Pituitary Tumor, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Malignant Glioma, Anaplastic Oligodendroglioma
Ask a Question
Further Information
Related Condition Support Groups
Related Drug Support Groups
prednisone, methotrexate, Cytoxan, cyclophosphamide, vincristine, Sterapred, Sterapred DS, Liquid Pred, Oncovin, view more... Deltasone, Methotrexate LPF Sodium, Meticorten, Orasone, Prednicot, Erwinaze, Elspar, Prednicen-M, Vumon, asparaginase escherichia coli, asparaginase erwinia chrysanthemi, teniposide, daunorubicin, Neosar, Cerubidine, Cytoxan Lyophilized, Vincasar PFS, Trexall, Folex PFS